Apyx Medical Q4 GAAP EPS $(0.28) May Not Be Comparable To $(0.18) Estimate, Sales $14.66M Miss $14.85M Estimate

Author: Benzinga Newsdesk | March 21, 2024 07:01am
Apyx Medical (NASDAQ:APYX) reported quarterly losses of $(0.28) per share which missed the analyst consensus estimate of $(0.18) by 55.56 percent. This is a 64.71 percent decrease over losses of $(0.17) per share from the same period last year. The company reported quarterly sales of $14.66 million which missed the analyst consensus estimate of $14.85 million by 1.27 percent. This is a 16.26 percent increase over sales of $12.61 million the same period last year.

Posted In: APYX